Canopy Growth (CGC) News
Latest news and analysis
Canopy Growth Surges 30% as Cannabis Stocks Regain Momentum
CGC's recent rally reflects broader sector recovery as investors reassess cannabis fundamentals amid evolving regulatory landscape and operational improvements.
Canopy Growth Rally Faces Skepticism Amid Structural Headwinds
CGC shares surge but analysts question sustainability given ongoing losses and competitive pressures in cannabis sector
Canopy Growth's 25% Rally Masks Deeper Fundamental Concerns
CGC surges 25% in four weeks, but technical bounce fails to address core profitability challenges and shrinking market position in competitive landscape.
Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III
AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.
CGC Surges on Federal Cannabis Rescheduling Progress
Canopy Growth shares rally as DEA advances marijuana rescheduling process, potentially unlocking major tax benefits for US cannabis operators.
Canopy Growth Surges on Federal Cannabis Rescheduling Progress
CGC stock jumps as DEA advances marijuana rescheduling from Schedule I to III, potentially unlocking major tax benefits for cannabis operators.
Major Cannabis Stocks Plunge on Rescheduling Reality Check
TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.
Cannabis Stocks Plunge as Rescheduling Optimism Fades
Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.
Canopy Growth Surges on Federal Cannabis Rescheduling Momentum
CGC shares jump as DEA moves closer to reclassifying marijuana from Schedule I to Schedule III, potentially unlocking major tax benefits for U.S. cannabis operators.
Canopy Growth Faces Mounting Pressure as Cannabis Sector Struggles
CGC stock continues decline amid sector-wide challenges, with ETF outflows signaling broader investor retreat from cannabis equities.
Cannabis Giants TLRY, CGC Rally on Federal Policy Breakthrough
Major cannabis stocks surge as Washington delivers long-awaited regulatory shift, sending Tilray and Canopy Growth shares climbing on institutional optimism.
Canopy Growth Bets on Tweed Brand Revival Amid Market Struggles
CGC launches summer marketing push for flagship Tweed brand as company fights for Canadian market share against budget competitors.
CGC Surges as Cannabis Rescheduling Momentum Builds
Canopy Growth shares climb on renewed federal rescheduling optimism, but investors should temper expectations given regulatory timeline uncertainties.
Trump Cannabis Reclassification Signals Drive ETF Surge
Cannabis ETFs rally on Trump administration rescheduling momentum as investors position for regulatory shift
Canopy Growth's 99.8% Stock Collapse: Dead Money or Contrarian Bet?
CGC trades near $1 after falling from $500 highs, raising questions about whether the cannabis giant represents value or a value trap.
Canopy Growth's $500-to-$1 Collapse: Analyzing the Turnaround Potential
CGC stock has plummeted from $500 highs to single digits. We analyze whether this represents a value opportunity or continued decline ahead.
Canopy Growth's 99.8% Decline: Analyzing the Cannabis Giant's Collapse
CGC trades near $1 after falling from $500 highs, raising questions about whether the cannabis pioneer can execute a turnaround or faces continued decline.
Three Cannabis Giants Face Regulatory Crossroads: TLRY, CGC, ACB Compared
Major cannabis operators Tilray, Canopy Growth, and Aurora Cannabis position differently as federal policy shifts loom over the sector's future.
CGC Stock Gains on Strategic Product Portfolio Expansion
Canopy Growth's new product launches drive investor confidence as company pivots toward higher-margin categories amid cannabis sector consolidation.